Biogen Revenue Down as Multiple Sclerosis Sales Slide

Date:




Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Kids build reading confidence with the help of a 4-pawed audience

Kids build reading confidence with the help of a...

Highly sensitive radio telescope array to be built in Nevada desert

Nestled in the Great Basin, a remote stretch of...

One person injured after shooting at Santa Fe Place Mall

SANTA FE, N.M. (KRQE) – The Santa Fe Police Department...